Direct Oral Anticoagulant Market Size, Share, Growth, Trends, Production, Consumption and Forecast 2019-2026

The Direct Oral Anticoagulant market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report is structured on primary and secondary research methodologies that derive historic and forecast data. The global Direct Oral Anticoagulant market is growing remarkably fast and is likely to thrive in terms of volume and revenue during the forecast period. Readers can gain insight into the various opportunities and restraints shaping the market. The report demonstrates the progress and bends that will occur during the forecast period.

The report provides size (in terms of volume and value) of Direct Oral Anticoagulant market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Direct Oral Anticoagulant market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Direct Oral Anticoagulant market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Direct Oral Anticoagulant market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Direct Oral Anticoagulant market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Direct Oral Anticoagulant market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Direct Oral Anticoagulant industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Direct Oral Anticoagulant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Direct Oral Anticoagulant market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Direct Oral Anticoagulant market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Direct Oral Anticoagulant market. These factors have benefited the growth of the global market for Direct Oral Anticoagulant. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Direct Oral Anticoagulant. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

Segment Analysis

The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Following are the segments covered by the report are:

By Product Types

Apixaban

Dabigatran

Rivaroxaban

Edoxaban

By Application:

Hospitals Pharmacies

Drug Stores

Online Pharmacies

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The Key manufacturers that are operating in the global Direct Oral Anticoagulant market are:

Bristol-Meyers Squibb Co

Pfizer Inc.

Boehringer Ingelheim Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc.

Bayer AG

Teva Pharmaceutical Industries Ltd

Pab Organics Private Limited

Daiichi Sankyo Company, Limited

Competitive Landscape

In this study, the years considered to estimate the market size of Direct Oral Anticoagulant are as follows:

  • History Year: 2015-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2026

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are: 

  • To analyze and study the global market capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

 

1 Market Overview

    1.1 Product Overview and Scope of Direct Oral Anticoagulant

    1.2 Direct Oral Anticoagulant Segment by Type

        1.2.1 Global Direct Oral Anticoagulant Sales Growth Rate Comparison by Type (2021-2026)

        1.2.2 Apixaban

        1.2.3 Dabigatran

        1.2.4 Rivaroxaban

        1.2.5 Edoxaban

    1.3 Direct Oral Anticoagulant Segment by Application

        1.3.1 Direct Oral Anticoagulant Sales Comparison by Application: 2020 VS 2026

        1.3.2 Hospitals Pharmacies

        1.3.3 Drug Stores

        1.3.4 Online Pharmacies

    1.4 Global Direct Oral Anticoagulant Market Size Estimates and Forecasts

        1.4.1 Global Direct Oral Anticoagulant Revenue 2015-2026

        1.4.2 Global Direct Oral Anticoagulant Sales 2015-2026

        1.4.3 Direct Oral Anticoagulant Market Size by Region: 2020 Versus 2026

 

2 Market Competition by Manufacturers

    2.1 Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2015-2020)

    2.2 Global Direct Oral Anticoagulant Revenue Share by Manufacturers (2015-2020)

    2.3 Global Direct Oral Anticoagulant Average Price by Manufacturers (2015-2020)

    2.4 Manufacturers Direct Oral Anticoagulant Manufacturing Sites, Area Served, Product Type

    2.5 Direct Oral Anticoagulant Market Competitive Situation and Trends

        2.5.1 Direct Oral Anticoagulant Market Concentration Rate

        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    2.7 Primary Interviews with Key Direct Oral Anticoagulant Players (Opinion Leaders)

 

3 Market Scenario by Region

    3.1 Global Direct Oral Anticoagulant Retrospective Market Scenario in Sales by Region: 2015-2020

    3.2 Global Direct Oral Anticoagulant Retrospective Market Scenario in Revenue by Region: 2015-2020

    3.3 North America Direct Oral Anticoagulant Market Facts & Figures by Country

        3.3.1 North America Direct Oral Anticoagulant Sales by Country

        3.3.2 North America Direct Oral Anticoagulant Sales by Country

        3.3.3 U.S.

        3.3.4 Canada

    3.4 Europe Direct Oral Anticoagulant Market Facts & Figures by Country

        3.4.1 Europe Direct Oral Anticoagulant Sales by Country

        3.4.2 Europe Direct Oral Anticoagulant Sales by Country

        3.4.3 Germany

        3.4.4 France

        3.4.5 U.K.

        3.4.6 Italy

        3.4.7 Russia

    3.5 Asia Pacific Direct Oral Anticoagulant Market Facts & Figures by Region

        3.5.1 Asia Pacific Direct Oral Anticoagulant Sales by Region

        3.5.2 Asia Pacific Direct Oral Anticoagulant Sales by Region

        3.5.3 China

        3.5.4 Japan

        3.5.5 South Korea

        3.5.6 India

        3.5.7 Australia

        3.5.8 Taiwan

        3.5.9 Indonesia

        3.5.10 Thailand

        3.5.11 Malaysia

        3.5.12 Philippines

        3.5.13 Vietnam

    3.6 Latin America Direct Oral Anticoagulant Market Facts & Figures by Country

        3.6.1 Latin America Direct Oral Anticoagulant Sales by Country

        3.6.2 Latin America Direct Oral Anticoagulant Sales by Country

        3.6.3 Mexico

        3.6.3 Brazil

        3.6.3 Argentina

    3.7 Middle East and Africa Direct Oral Anticoagulant Market Facts & Figures by Country

        3.7.1 Middle East and Africa Direct Oral Anticoagulant Sales by Country

        3.7.2 Middle East and Africa Direct Oral Anticoagulant Sales by Country

        3.7.3 Turkey

        3.7.4 Saudi Arabia

        3.7.5 U.A.E

4 Market Analysis by Type

    4.1 Global Direct Oral Anticoagulant Sales Market Share by Type (2015-2020)

    4.2 Global Direct Oral Anticoagulant Revenue Market Share by Type (2015-2020)

    4.3 Global Direct Oral Anticoagulant Price Market Share by Type (2015-2020)

    4.4 Global Direct Oral Anticoagulant Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

 

5 Market Analysis by Application

    5.1 Global Direct Oral Anticoagulant Sales Market Share by Application (2015-2020)

    5.2 Global Direct Oral Anticoagulant Revenue Market Share by Application (2015-2020)

    5.3 Global Direct Oral Anticoagulant Price by Application (2015-2020)

 

6 Company Profiles and Key Figures in Direct Oral Anticoagulant Business

    6.1 Bristol-Meyers Squibb Co

        6.1.1 Corporation Information

        6.1.2 Bristol-Meyers Squibb Co Description, Business Overview and Total Revenue

        6.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)

        6.1.4 Bristol-Meyers Squibb Co Products Offered

        6.1.5 Bristol-Meyers Squibb Co Recent Development

    6.2 Pfizer Inc.

        6.2.1 Pfizer Inc. Direct Oral Anticoagulant Production Sites and Area Served

        6.2.2 Pfizer Inc. Description, Business Overview and Total Revenue

        6.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)

        6.2.4 Pfizer Inc. Products Offered

        6.2.5 Pfizer Inc. Recent Development

    6.3 Boehringer Ingelheim Pharmaceuticals, Inc

        6.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Production Sites and Area Served

        6.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Description, Business Overview and Total Revenue

        6.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)

        6.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Products Offered

        6.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Recent Development

    6.4 Janssen Pharmaceuticals, Inc.

        6.4.1 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Production Sites and Area Served

        6.4.2 Janssen Pharmaceuticals, Inc. Description, Business Overview and Total Revenue

        6.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)

        6.4.4 Janssen Pharmaceuticals, Inc. Products Offered

        6.4.5 Janssen Pharmaceuticals, Inc. Recent Development

    6.5 Bayer AG

        6.5.1 Bayer AG Direct Oral Anticoagulant Production Sites and Area Served

        6.5.2 Bayer AG Description, Business Overview and Total Revenue

        6.5.3 Bayer AG Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)

        6.5.4 Bayer AG Products Offered

        6.5.5 Bayer AG Recent Development

    6.6 Teva Pharmaceutical Industries Ltd

        6.6.1 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Production Sites and Area Served

        6.6.2 Teva Pharmaceutical Industries Ltd Description, Business Overview and Total Revenue

        6.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)

        6.6.4 Teva Pharmaceutical Industries Ltd Products Offered

        6.6.5 Teva Pharmaceutical Industries Ltd Recent Development

    6.7 Pab Organics Private Limited

        6.6.1 Pab Organics Private Limited Direct Oral Anticoagulant Production Sites and Area Served

        6.6.2 Pab Organics Private Limited Description, Business Overview and Total Revenue

        6.6.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)

        6.4.4 Pab Organics Private Limited Products Offered

        6.7.5 Pab Organics Private Limited Recent Development

    6.8 Daiichi Sankyo Company, Limited

        6.8.1 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Production Sites and Area Served

        6.8.2 Daiichi Sankyo Company, Limited Description, Business Overview and Total Revenue

        6.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2015-2020)

        6.8.4 Daiichi Sankyo Company, Limited Products Offered

        6.8.5 Daiichi Sankyo Company, Limited Recent Development

 

7 Direct Oral Anticoagulant Manufacturing Cost Analysis

    7.1 Direct Oral Anticoagulant Key Raw Materials Analysis

       7.1.1 Key Raw Materials

       7.1.2 Key Raw Materials Price Trend

       7.1.3 Key Suppliers of Raw Materials

    7.2 Proportion of Manufacturing Cost Structure

    7.3 Manufacturing Process Analysis of Direct Oral Anticoagulant

    7.4 Direct Oral Anticoagulant Industrial Chain Analysis

 

8 Marketing Channel, Distributors and Customers

    8.1 Marketing Channel

    8.2 Direct Oral Anticoagulant Distributors List

    8.3 Direct Oral Anticoagulant Customers

 

9 Market Dynamics

9.1 Market Trends

9.2 Opportunities and Drivers

9.3 Challenges

9.4 Porter's Five Forces Analysis

 

10 Global Market Forecast

    10.1 Global Direct Oral Anticoagulant Market Estimates and Projections by Type

        10.1.1 Global Forecasted Sales of Direct Oral Anticoagulant by Type (2021-2026)

        10.1.2 Global Forecasted Revenue of Direct Oral Anticoagulant by Type (2021-2026)

    10.2 Direct Oral Anticoagulant Market Estimates and Projections by Application

        10.2.1 Global Forecasted Sales of Direct Oral Anticoagulant by Application (2021-2026)

        10.2.2 Global Forecasted Revenue of Direct Oral Anticoagulant by Application (2021-2026)

    10.3 Direct Oral Anticoagulant Market Estimates and Projections by Region

        10.3.1 Global Forecasted Sales of Direct Oral Anticoagulant by Region (2021-2026)

        10.3.2 Global Forecasted Revenue of Direct Oral Anticoagulant by Region (2021-2026)

    10.4 North America Direct Oral Anticoagulant Estimates and Projections (2021-2026)

    10.5 Europe Direct Oral Anticoagulant Estimates and Projections (2021-2026)

    10.6 Asia Pacific Direct Oral Anticoagulant Estimates and Projections (2021-2026)

    10.7 Latin America Direct Oral Anticoagulant Estimates and Projections (2021-2026)

    10.8 Middle East and Africa Direct Oral Anticoagulant Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

 

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers